Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Grb10, an adapter protein, is a member of the Grb7/Gr10/Grb14 protein family. These proteins interact with a number of receptor tyrosine kinases, impacting a variety of signaling pathways. Specifically, Grb10 has been implicated in the regulation of cell proliferation, metabolism, and apoptosis, among other functions.
Grb10 expression was initially identified in mouse fibroblasts. Although a low level Grb10 mRNA expression was detected in mouse liver, abundant mRNA expression was detected in skeletal muscle, brain, heart, liver, cartilage and in adipose tissue. In humans, higher Grb10 expression was detected in pancreas and skeletal muscle, intermediate expression was detected in brain and cardiac muscle, and lower expression was reported in liver, kidney, lung, placenta, spleen, prostate, ovary, colon, testis and in small intestine. The mRNA expression of Grb10 has been found to be upregulated in primary cervical squamous cell cancers and depletion of Grb10 mRNA by siRNA resulted in marked cell growth inhibition of the cervical squamous cell indicating that Grb10 acts as a survival factor in this disease.
Grb10 is an imprinted gene
Imprinted genes, defined by their preferential expression of a single parental allele, represent a subset of the mammalian genome and often have important roles in embryonic development, but also postnatal functions including energy homeostasis and behavior. Grb10 is expressed from the maternal chromosome in most tissues in the mouse but is expressed from the paternal allele in a subset of neurons. Maternal expression occurs from the Grb10 major promoter whereas Grb10 paternal expression comes from three downstream alternative promoters. The region surrounding one of these alternative promoters has been identified as an ICR, which exhibits DNA methylation only on the maternal allele in all examined tissues. On the paternal allele, the unmethylated Grb10 ICR is bound by CCCTC-binding factor (CTCF), a multifunctional transcription factor, which is recruited in a DNA methylation-sensitive manner and has been implicated in the regulation of imprinted expression at other loci. Therefore, Grb10 is an imprinted gene with multiple functions and a complex tissue-specific imprinted expression pattern.
Grb10 protein partners
In mouse and human, Grb10 has five major protein domains: a centrally located pleckstrin homology domain (PH), the N-terminal proline-rich region (PR), a Ras-associating domain (RA), a C-terminal Src homology 2 domain (SH2), and the family specific BPS domain, so named because it is between the PH and SH2 domains. Each domain is associated with protein binding partners that define the functions of Grb10 in development and growth (Figure 1).
Figure 1. Grb10 protein partners.
The SH2 domain enables Grb10 to interact with phosphorylated tyrosine residues of other proteins and plays as the recruitment point for a variety of signaling molecules. Many of these proteins are receptors associated with growth, including the growth hormone receptor (GHR) and the insulin receptor (IR). The SH2 domain is key for the role of Grb10 in the mitogen-activated protein kinase (MAPK) pathway, having direct interactions with numerous critical components including MEK1 and RAF1. The BPS domain, specific to the Grb7/10/14 protein family, has also been shown to be important for Grb10’s role in insulin signaling through its binding to IR and additionally binds IGF1R. The BPS domain interacts with the 14-3-3 protein, another protein scaffold with numerous protein partners, and BCL2L11, a proapoptotic scaffold protein required for normal immune function.
The role of Grb10 in insulin receptors signaling
The role of Grb10 in insulin receptors signaling Grb10 was found to be associated with InsR in response to the insulin stimulation and this association resulted in negative regulation of insulin signaling. Similar to InsR, insulin-like growth factor 1 receptor (IRS-1R) associated with Grb10 and the association was mediated through the carboxy-terminus of activated receptor. Nevertheless, unlike other InsR interacting proteins, Grb10 did not associate with the insulin receptor substrate-1 (IRS-1) suggesting that Grb10 plays a unique role in the insulin signaling independent of IRS-1. Although Grb10 has been shown to negatively regulate the insulin signaling, contradictory results have also been reported. Microinjection of the SH2 domain of Grb10 in fibroblasts blocked insulin and IGF-1 induced mitogenesis but had no effect on the EGF-induced mitogenesis suggesting that Grb10 cooperates with insulin in downstream signaling. In addition, in response to IGF-1, PDGF, and insulin, Grb10 potentiates cell proliferation. This biological effect is mediated through the association of Grb10 with Gab1. Overexpression of mouse Grb10a in p6 or other mouse embryo fibroblast cell lines partially blocked insulin-induced transformation but not cell proliferation. Therefore, Grb10 acts differentially in InsR signaling.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.